English
Transgene Biotek Q1 Results
- BSE: 526139
- NSE: -
- ISIN: INE773D01018
- Sector: Biotechnology & Drugs
BSE
2.46
0.00 (0.00%)
0.00 (0.00%)Volume24.64 K
Updated: Wed 21 Jan, 2026 | 13:20:37
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Transgene Biotek Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 0.24 | 0.64 | -63.00% | 0.48 | -50.92% |
| Depreciation/ Amortization | 0.05 | 0.02 | 111.91% | 0.02 | 114.66% |
| Operating Income | -0.19 | -0.57 | -66.74% | -0.44 | -56.75% |
| Net Income | -0.43 | -0.71 | -39.18% | 0.20 | 0.00% |
| Other Operating Expenses Total | 0.14 | 0.56 | -74.67% | 0.38 | -62.99% |
| Net Income Before Taxes | -0.43 | -0.71 | -39.18% | 0.20 | 0.00% |
| Total Revenue | 0.05 | 0.08 | -35.29% | 0.05 | 0.61% |
| Selling/ General/ Admin Expenses Total | 0.05 | 0.06 | -25.55% | 0.08 | -41.66% |
| Diluted Normalized EPS | -0.06 | -0.09 | -36.24% | 0.03 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.